Updates

Cineworld - Acquires five cinemas for Â£94m

October 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

As a consumer stock you might expect Cineworld to have been pummelled after Brexit but the shares have bounced to hit an all-time high of 618p. This was helped by the acquisition of five cinemas for £94m, including the plum nine screen Empire Leicester Square multiplex.Half the consideration is funded in debt and the other half by 8.2m new shares. In total the acquisition has brought in 64 screens and generated £9m EBITDA in 12 months ended 31 March, albeit that doesn’t include additional screens opened part-way in the period. The deal will be marginally eps enhancing in 2016 and “materially” eps enhancing in FY ’17 including synergies.Since then Cineworld released interims showing turnover ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Bovis - Shares make strong recovery

Cranswick

Cineworld - Exciting film slate and pent up demand could drive re-rating (September 2021)

Cineworld (April 2020)

Cineworld (February 2020)

Cineworld (September 2019)

Cineworld - Sale and leaseback yields special dividend (July 2019)

Cineworld - Results trigger broker upgrades (May 2019)

Cineworld - Cinema chain transformed by US acquisition (April 2019)

Cineworld (July 2018)

Cineworld - Transformational US acquisition (March 2018)

Cineworld - Cinema operator boosted by Hollywood blockbuster (October 2017)

Cineworld (July 2017)

Cineworld (May 2016)

Cineworld (March 2016)

Cineworld (October 2015)

Cineworld - Cinema chain to benefit from strong film release schedule (September 2015)

Cineworld - Second largest cinema chain expanding rapidly (July 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X